Hope for multiple sclerosis sufferers after green light for drug which can delay wheelchair use by seven years

Hope for multiple sclerosis sufferers after green light for drug which can delay wheelchair use by seven years Multiple Sclerosis (MS) patients have welcomed an NHS decision to fund a “landmark” drug which can delay the need for a wheelchair by seven years.

Health chiefs have announced they will soon make available ocrelizumab, the first effective medicine for people suffering from the early primary progressive form of the disease.

It follows an outcry last September after the National Institute for Health and Care Excellence (Nice), which decides which treatments should be routinely paid for by the health service, rejected the drug due to its cost. The Daily Telegraph

See also:

• We both now have hope - MS sisters BBC News
• Health watchdog approves first ever treatment for progressive form of MS in massive U-turn The Daily Mail
• New drug for multiple sclerosis patients after maker drops price The Guardian